Cargando…
Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study
BACKGROUND AND OBJECTIVES: Preoperative use of renin angiotensin system antagonists has been considered an independent risk factor for development of vasoplegic syndrome. The aim of this study was to demonstrate efficacy of prophylactic terlipressin infusion for prevention of vasoplegic syndrome in...
Autores principales: | Saleh, Mohamed, Kodeira, Sherine Kamal Zaki, Aboulseoud, Abdelkhalek Abdelmoneim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296192/ http://dx.doi.org/10.1186/s42077-020-0054-6 |
Ejemplares similares
-
Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study
por: Papadopoulos, Georgios, et al.
Publicado: (2010) -
Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020) -
Rebound hypotension following terlipressin bolus infusion can be prevented by continuous low-dose infusion of terlipressin
por: Lange, M, et al.
Publicado: (2007) -
Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report
por: Šribar, Andrej, et al.
Publicado: (2023) -
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)